Virtue Recovery Center’s Post

Unlocking Hope: The Powerful Impact of MOUD Key Takeaways MOUD includes FDA-approved medications like methadone, buprenorphine, and naltrexone to treat opioid use disorder (OUD). MOUD treatment can reduce withdrawal symptoms, prevent overdose, and support long-term recovery. Integrating MOUD with behavioral therapies enhances treatment outcomes. MOUD is available through various opioid treatment programs and primary care providers. Access to MOUD is crucial for […] The post Unlocking Hope: The Powerful Impact of MOUD appeared first on Virtue Recovery Houston. https://lnkd.in/gQJ4SGSh

NON-CONSENSUAL OPIOID DEPRESCRIBING IS NOT JUSTIFIED. Long-term opioids are safe and effective in the management of chronic non-cancer pain when used APPROPRIATELY in a significant subgroup of people. Yet popular opinion in medical circles these days in the Western world, seems to be in favour of introducing mandatory policies of involuntary or non-consensual opioid tapering across the board, irrespective of the benefits for many people with Severe Chronic Secondary Pain. The following American Analysis clearly outlines why "harm to some individuals undergoing forced taper" is a valid concern, and gives examples why a one-size-fits-all approach is "not Justified Clinically or Ethically." Australian policy makers should take note, and NOT force-taper those chronic pain patients who, on balance, show beneficial outcomes when on longterm opioid therapy [LTOT]. #Australia #America #painrelief #nonconsensual #forcedtapers #opioidtapering #deprescribing #chronicsecondarypain #severedisablingpain #persistentpain #opioidguidelines #chronicpainmanagement #noonesizefitsall #patientadvocacy #multidisciplinarycare #selfmanagement #medicalgaslighting #undertreatedpain #prescriptionopioids #opioidcrisis #opioidepidemic #addiction #dependence #overdose #opioidrestrictions #opiophobia #opioidhysteria #holisticcare #qualityoflife #humanrights #education #stopthestigma #dontpunishpain https://lnkd.in/gBwEXhqX

Join us next week for our next virtual RCA Academy Event presented by Dr. Steve Holtsford! Register to save your seat: https://lnkd.in/eQmC8tra During this course, you will learn: ⭐The difference between Drug-Free and (MAT) Medication Assisted Therapy and the vulnerability of an opioid overdose. ⭐ Risk Mitigation in the context of Medication Assisted Therapy for Opioid Use Disorder. ⭐ The vulnerability of an opioid overdose with Vivitrol, at the end of a dosing interval, after missing a scheduled dose, or after discontinuing treatment.

In this session, Michael D. Cheshire, DO, FACOI, FACP, will discuss how to accurately assess patients in pain, develop a safe and effective pain treatment plan, identify evidence-based non-opioid options for the treatment of pain, and recognize behaviors that may be associated with opioid use disorder. Session participants will also learn to identify the risks and benefits of opioid therapy and how to manage ongoing therapy with patients. https://bit.ly/3wo4nhi #cme #opioid #DOProud #OsteopathicMedicine

In this session, Michael D. Cheshire, DO, FACOI, FACP, will discuss how to accurately assess patients in pain, develop a safe and effective pain treatment plan, identify evidence-based non-opioid options for the treatment of pain, and recognize behaviors that may be associated with opioid use disorder. Session participants will also learn to identify the risks and benefits of opioid therapy and how to manage ongoing therapy with patients. https://bit.ly/3wo4nhi #cme #opioid #DOProud #OsteopathicMedicine

In this session, Michael D. Cheshire, DO, FACOI, FACP, will discuss how to accurately assess patients in pain, develop a safe and effective pain treatment plan, identify evidence-based non-opioid options for the treatment of pain, and recognize behaviors that may be associated with opioid use disorder. Session participants will also learn to identify the risks and benefits of opioid therapy and how to manage ongoing therapy with patients. https://bit.ly/3wo4nhi #cme #opioid #DOProud #OsteopathicMedicine

Community, It's Time to Come Together and Fight the Good Fight Many individuals are diagnosed with autoimmune diseases, facing chronic pain and complex treatment regimens. Unfortunately, a growing number of patients are becoming addicted to opioids, which are commonly prescribed to manage their pain. In New York State, health professionals are not only prescribing opioid medications but also providing Narcan to patients as a precaution against potential overdoses. This situation underscores the severity of the opioid crisis we are facing. Recently, there has been a shift towards prescribing anti-inflammatory medications to help manage pain, which raises the question: Why wasn't this discovered and prioritized earlier? The reality is that pharmaceutical companies have historically profited immensely from the sale of opioids, often at the expense of patient health and safety. It's crucial that we bring awareness to these issues. Together, we can advocate for safer, more effective pain management strategies and support those struggling with both autoimmune diseases and opioid addiction. Let's unite to raise awareness and fight for better healthcare solutions. https://lnkd.in/ejRj6Evt #thehardtruthsaboutselfcare #harmreduction #awareness #commuity #jselfcare #selfcarejsinc #jsselfcareisdope #commuity #awareness #education #choices

How to effectively collaborate with MOUD providers for patient care: Understanding the importance of collaboration with Medication for Opioid Use Disorder (MOUD) providers is key to ensuring optimal care. Here are some essential points to consider: - Be aware of PDMP limitations: Methadone for addiction treatment may not be visible in certain Prescription Drug Monitoring Programs, like in Wisconsin. - Exercise caution with sedating medications: Benzodiazepines and other sedatives can heighten overdose risks when combined with MOUD. Prescribe these medications carefully. - Respect medical management: Refrain from commenting on MOUD dosages managed by other medical providers. - Support individual recovery: Avoid imposing personal opinions on someone else's recovery journey. - Prioritize confidentiality: MOUD treatment demands heightened confidentiality standards compared to other medical care. - Promote equitable treatment: Approach MOUD treatment with the same respect as insulin therapy. - Break down barriers: Seize every chance to eliminate obstacles to treatment. For inquiries or collaborations with a MOUD provider, reach out to CMS Pewaukee at 262-304-0150. Let's join forces to foster a supportive and effective environment for individuals on their path to recovery. #AddictionRecovery #MOUD #HealthcareCollaboration #PatientCare #MentalHealth #Waukesha #Overdose

Amidst the complexities of addressing opioid use disorder, the repeal of the "X-waiver" by Congress aimed to expand access to the life-saving buprenorphine-naloxone treatment. However, the expected surge in prescribing hasn't materialized, prompting a critical question: Why? Despite increasing recognition of the importance of treatment, providers seem hesitant. Research from RTI International, utilizing a simulation model, reveals that increasing non-prescribed buprenorphine in communities could decrease overdoses by 3 - 6%. Invest in Safe Supply today. Click the link to know more: www.safesupply.com https://bit.ly/48Bs4R4

Transportation barriers have long been associated with poorer health outcomes; this burden is especially acute for individuals with opioid use disorder. The treatment is so critical for the individual’s survival, but yet so hard to gain access to if they have a transportation challenge. I feel in most cases the individuals just succumbs to the disease because they can’t get the help they need quick enough. We have to do better at getting more facilities and providers or better at helping with transportation barriers.